First Community Trust NA Grows Position in DENTSPLY SIRONA Inc. $XRAY

First Community Trust NA grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 66.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,090 shares of the medical instruments supplier’s stock after purchasing an additional 6,000 shares during the period. First Community Trust NA’s holdings in DENTSPLY SIRONA were worth $240,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. boosted its position in DENTSPLY SIRONA by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock worth $309,864,000 after purchasing an additional 557,329 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in DENTSPLY SIRONA by 11.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock worth $208,590,000 after purchasing an additional 1,412,517 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its position in shares of DENTSPLY SIRONA by 4.7% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier’s stock valued at $180,445,000 after buying an additional 538,531 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of DENTSPLY SIRONA by 119.4% during the 1st quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier’s stock valued at $93,423,000 after buying an additional 3,453,662 shares in the last quarter. Finally, Edmond DE Rothschild Holding S.A. lifted its position in shares of DENTSPLY SIRONA by 26.4% during the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 2,913,400 shares of the medical instruments supplier’s stock valued at $43,526,000 after buying an additional 609,300 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Wells Fargo & Company decreased their target price on DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a research report on Friday, August 8th. Wall Street Zen lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Barrington Research decreased their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, August 8th. Finally, Stifel Nicolaus reduced their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research note on Friday, August 8th. Two analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $18.64.

DENTSPLY SIRONA Stock Down 2.9%

NASDAQ XRAY opened at $13.53 on Friday. The business has a fifty day moving average price of $14.73 and a 200 day moving average price of $15.02. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $27.48. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The company has a market cap of $2.70 billion, a P/E ratio of -2.85, a P/E/G ratio of 0.87 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. During the same period in the prior year, the company earned $0.49 EPS. The firm’s revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.7%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -13.50%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.